Amplify Treatments, Testing And Advancements ETF DVAX Holdings History
Amplify Treatments, Testing and Advancements ETF's Dynavax Technologies Corp Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 28,625.00 shares of Dynavax Technologies Corp(DVAX), totaling $321,460.00. This investment constitutes 3.52% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0.02% of the outstanding Dynavax Technologies Corp(DVAX) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $11.64 for 4,988.00 shares. Based on historical transaction data and DVAX's current price of $11.18, Amplify Treatments, Testing and Advancements ETF's estimated gain on his DVAX holdings is $-60,225.70, reflecting a -13.74% gain to date.
Amplify Treatments, Testing and Advancements ETF DVAX ($11.18) Holding Chart
Amplify Treatments, Testing and Advancements ETF DVAX ($11.18) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
